[1] Stefanie L, Amanda L, Katie E, et al. "You'll have to be my eyes and ears": A conversation analytic study of physical examination on a health helpline. J Clin Nurs, 2019, 28: 330-339. [2] Coelho DRM, Marinho Rui T, Teresa R. Mortality associated with hepatobiliary disease in portugal between 2006 and 2012. GE Port J Gastroenterol, 2018, 25: 123-131. [3] Wills Edgar S, Cnossen Wybrich R, Veltman Joris A, et al. Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes. Eur J Hum Genet, 2016, 24: 1707-1714. [4] Hiraki Y, Kirmura Y, Makari Y, et al. Three cases of bleeding from advanced gastric cancer treated by transcatheter arterial embolization (TAE) and continued chemotherapy. Gan To Kagaku Ryoho, 2015, 42(12): 1965-1967. [5] Neijenhuis MK, Wijnands FM, Kievit W, et al. Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts. Eur Radiol, 2018, 134(11)1306-1315. [6] Salceda JA, Bracco R, Fernandez D. Timing and treatment options in adult polycystic liver disease: a rare familiar case as example. Arq Bras Cir Dig, 2018, 31: e1411. [7] Le RB, Cauchy F, Sepulveda A, et al. Modified technique of total hepatectomy in polycystic liver disease with caval flow preservation: the exposure left lateral sectionectomy. Transplantation, 2018, 14(6):89-96. [8] 曹海霞,范建高. 肝硬化患者营养评估及营养支持治疗. 实用肝脏病杂志, 2014, 17(5): 459-462. [9] 段钟平. 肝病营养问题再关注. 实用肝脏病杂志, 2014, 17(5): 449-451. [10] Savigc J, Mallctt A, Tunnicliffc DJ, et al. KHA-CARI autosomal dominant polycystic kidney disease guideline: management of polycystic liver disease. Semin Nephrol, 2015, 35(6): 618-622. [11] Kawada M, Hayami N, Suwade T, et al. Hepatocellular carcinoma ina patient with polycystic liver disease. Intern Med, 2015, 54(15): 1891-1896. [12] Bernts LH, Echternach SG, Kievit W, et al. Clinical response after laparoscopic fenestration of symptomatic hepatic cysts: a systematic review and meta-analysis. Surg Endosc, 2019, 33(3): 691-704. [13] Stoore C, Andrade C, Hidalgo C, et al. Echinococcus granulosus hydatid cyst location is modified by fasciola hepatica infection in cattle. Parasit Vectors, 2018, 11(9): 542-549. [14] 王文娟,白梅,蔡江涛,等. 肝脏超声造影诊断肝癌术后肝内肿瘤复发的价值探讨. 实用肝脏病杂志, 2016, 19(2): 214-216. [15] Pech L, Favelier S, Falcoz, MT, et al. Cercueil imaging of vonmeyenburg complexes. Diagn Interv Imaging, 2016, 97(4): 401-409. [16] Dohan A, Faraoum SA, Barral M, et al. Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features. Diagn Interv Imaging, 2015, 96(9): 871-883. [17] Khan S, Dennison A, Garcea G. Medical therapy for polycystic liver disease. Ann R Coll Surg Engl, 2016, 98(1): 18-23. [18] Munoz P, Marin I J, Perugorria M J, et al. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease. J Hepatol, 2015, 63(4): 952-961. [19] D’ agnolo H M, Kievit W, Takkenberg R B, et al. Ursodeoxycholic acid in advanced polycystic liver disease: a phase 2 multicenter randomized controlled trial. J Hepatol, 2016, 65(3): 601-607. [20] Janeiro D, Portoles J, Marta Tato A, et al. Peritoneal dialysis can be an option for dominant polycystic kidney disease: an observational study. PeritDial Int, 2015, 35(5):530-536. |